Global Preclinical Imaging Market 2015-2019
About Pre-clinical Imaging
Pre-clinical Imaging is in vivo imaging of small animals, which had been progressively deployed in drug development process. It helps in the visualizing and monitoring of animals for research with respect to tissue, organ, cell (at molecular level), and physiological and environmental changes. One of the main application areas of pre-clinical imaging is early detection of diseases. Currently the most used imaging modalities are optical (fluorescence and bioluminescence), PET, and MRI. In addition, multi-modalities such as PET+CT and SPECT+CT are the most used imaging combinations. In vivo imaging is increasingly used in target identification, compound optimisation and pre-Phase I studies, and in the drug development process. Thus, it bridges the gap between in vitro exploratory and in vivo clinical research.
TechNavio's analysts forecast the Global Pre-clinical Imaging market to grow at a CAGR of 15.02 percent over the period 2014-2019.
Covered in this Report
This report covers the present scenario and growth prospects of the Global Pre-clinical Imaging market for the period 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of pre-clinical imaging systems. Pre-clinical imaging systems can be segmented based on the type of equipment, as mentioned below:
TechNavio Announces the Publication of its Research Report – Global Preclinical Imaging Market 2015-2019
TechNavio recognizes the following companies as the key players in the Global Preclinical Imaging Market: Aspect Imaging, Bruker Corp., Mediso Ltd., PerkinElmer Inc., Siemens Healthcare Corp. , Thermo Fisher Scientific Inc. and Trifoil Imaging Inc.
Other Prominent Vendors in the market are: Agilent Technologies, Capintec, GE Medical Systems, Hitachi Medical, LI-COR Biosciences, Miltenyi Biotec, Naviscan, Positron, Promega and Quintiles.
Commenting on the report, an analyst from TechNavio’s team said: “The use of multi-modalities imaging systems is a major trend in the market. Also, innovation and advances in technologies to meet research needs, safety, efficacy, and potential reversibility have resulted in the involvement of multi-modalities imaging systems.”
According to the report, an increase in R&D in pharma companies is one of the major drivers of the market. Because of the intense competition in the market, vendors try to develop new drugs and spend huge amounts toward drug development.
Further, the report states that high cost is a major challenge that the market faces. The cost required to complete preclinical studies depends on the research involved. Vendors spend huge amounts on R&D, which will have a significant effect on the company's economy.Aspect Imaging, Bioscan (Subsidiary of Trifoil Imaging), Bruker Corporation , Mediso Medical Imaging Systems, PerkinElmer, Siemens Healthcare , Thermo Fisher Scientific , Agilent Technologies, Capintec, Hitachi Medical, LI-COR Biosciences, Miltenyi Biotec GMBH, Naviscan,Positron, Promega, Quintiles
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook